Opendata, web and dolomites


Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala

Total Cost €


EC-Contrib. €






 URBACH-ALZ project word cloud

Explore the words cloud of the URBACH-ALZ project. It provides you a very rough idea of what is the project "URBACH-ALZ" about.

levels    dutch    hyper    started    caused    relation    cape    stronger    university    lausanne    uwd    deeper    basolateral    central    give    400    africa    projections    hypothesis    bilateral    correlating    cerebrospinal    south    disorders    ot    host    plan    personality    tests    handful    spread    center    amygdala    function    insecurely    neurobiological    uniquely    treat    hypothesize    anc    wie    attachment    occurring    chemogenetic    translational    onto    town    adding    causes    decrease    human    mri    individuals    decreased    oxytocin    profiles    patients    collaborators    rare    group    neurodegeneration    construct    animal    worldwide    behavioral    fear    cea    genetic    blood    anxiety    firm    ad    urbach    opto    functional    settlers    disease    bla    special    inhibitory    mutation    lab    damage    alzheimer    basis    causally    fluid    clinical    multidisciplinary    animals    found    causal    reported    model    chemogenetically    gt    attached    anatomical    signaling    gained   

Project "URBACH-ALZ" data sheet

The following table provides information about the project.


Organization address
address: VIA MOREGO 30
city: GENOVA
postcode: 16163

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 173˙634 €
 EC max contribution 173˙634 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2018-12-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

'I propose to test how hyper-anxiety in Alzheimer's disease (AD) patients is caused by neurodegeneration in the amygdala, our 'center of fear', by comparing with a unique group of Urbach Wiethe disease (UWD) patients with bilateral neurodegeneration of the amygdala (BLA) for which I also construct an animal model. UWD is caused by a very rare genetic mutation occurring in only a handful of individuals worldwide. My host in Lausanne has gained access, however, to a uniquely large group of UWD patients in South-Africa (>40) where the mutation has spread for 400 years in Dutch settlers. Our collaborators at Cape Town University have found, in anatomical & functional MRI and special behavioral tests, how specific loss of inhibitory projections from the basolateral (BLA) onto the central part of the amygdala (CeA) causes hyper-anxiety in UWD. Based upon recently reported BLA neurodegeneration in AD patients, I hypothesize a crucial BLA role in hyper-anxiety of AD patients. I plan to test this in AD patients with clinical collaborators in Lausanne and, to test this hypothesis causally, I have started to opto,- anc chemogenetically decrease BLA function in an animal model. In addition, in Lausanne a stronger hyper-anxiety was observed in AD patients with insecurely attached personality profiles. As my host lab has established an inhibitory role of oxytocin (OT) in the CeA, I hypothesize a decreased OT signaling in CeA of these patients, adding to the anxiety already caused by the BLA loss. I plan to test this both in AD and UWD patients by correlating attachment profiles with OT levels (in blood & cerebrospinal fluid) and anxiety levels & BLA damage (MRI). I will use opto&chemogenetic targeting of OT signaling in animals for a causal relation. This multidisciplinary and translational approach can give a deeper understanding of the role of the amygdala in hyper-anxiety in human patients, and provide a firm neurobiological basis for applying OT to treat anxiety disorders. '


year authors and title journal last update
List of publications.
2018 David Terburg, Diego Scheggia, Rodrigo Triana del Rio, Floris Klumpers, Alexandru Cristian Ciobanu, Barak Morgan, Estrella R. Montoya, Peter A. Bos, Gion Giobellina, Erwin H. van den Burg, Beatrice de Gelder, Dan J. Stein, Ron Stoop, Jack van Honk
The Basolateral Amygdala Is Essential for Rapid Escape: A Human and Rodent Study
published pages: 723-735.e16, ISSN: 0092-8674, DOI: 10.1016/j.cell.2018.09.028
Cell 175/3 2019-08-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "URBACH-ALZ" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "URBACH-ALZ" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)


Digital Poetry in Today’s Russia: Canonisation and Translation

Read More  

GENESE 17 (2018)

Geometries of Exotic NuclEar StructurE 17

Read More  

LearningEmotions (2020)

Emotion Recognition: A Statistical Learning Approach

Read More